Status | Study |
RECRUITING |
Study Name: A Study to Learn About the Amount of the Study Medicine (Sisunatovir) in Blood and Its Safety in Infants and Children With Pneumonia Caused by RSV Condition: Respiratory Syncytial Virus Infections Date: 2023-10-06 Interventions: Placebo |
RECRUITING |
Study Name: Prospective Surveillance of Respiratory Syncytial Virus Disease in Infants and Toddlers Condition: Respiratory Syncytial Virus Infections Date: 2023-07-07 |
RECRUITING |
Study Name: A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease and Compared to Healthy Adults 50 Years of Age and Above Condition: Respiratory Syncytial Virus Infections Date: 2023-06-16 Interventions: The investigational vaccine will be administered intramuscularly as 1 dose to RSV_IC_1 and RSV_HA groups, and 2 doses to RSV_IC_2 group). |
ACTIVE_NOT_RECRUITING |
Study Name: Study to Assess the Immune Response, the Safety and the Reactogenicity of Respiratory Syncytial Virus (RSV) Prefusion Protein 3 Older Adult (OA) (RSVPreF3 OA) Investigational Vaccine When co Administered With PCV20 in Older Adults Condition: Respiratory Syncytial Virus Infections Date: 2023-05-18 Interventions: One dose of RSVPreF3 OA vaccine given intramuscularly in participant's non-dominant arm on Day 1 (in the Coad group) or Day 31(in the Control gro |
RECRUITING |
Study Name: A Follow-up Study to Describe the Safety of Study Participants Who Received RSVPreF3 Maternal Vaccination (Any Dose) or Controls From Previous RSV MAT Studies During Any Pregnancy Conceived Post Vaccination/Control Condition: Respiratory Syncytial Virus Infections Date: 2023-01-20 Interventions: No intervention is administered in this extension study.Participants received the RSVPreF3 vaccine during the prior RSV MAT studies (RSV MAT-001 |
RECRUITING |
Study Name: A Study of BLB-201 RSV Vaccine in Infants and Children Condition: Respiratory Syncytial Virus Infections Date: 2022-12-08 Interventions: BLB201 10^6 PFU |
Completed |
Study Name: Phase Ia Study of XW001 in Healthy Adult Subjects Condition: Respiratory Syncytial Virus Infections Date: 2022-11-30 Interventions: Interventional |
RECRUITING |
Study Name: Safety and Immunogenicity of CodaVax-RSV in Seropositive and Seronegative Children Condition: Respiratory Syncytial Virus Infections Date: 2021-05-26 Interventions: live attenuated vaccine against RSV |
Recruiting |
Study Name: Evaluating the Infectivity, Safety, and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants 6 to 24 Months of Age Condition: Respiratory Syncytial Virus Infections Date: 2017-03-23 Interventions: Biological: D46/NS2/N/ΔM2-2-HindIII |
Recruiting |
Study Name: Viral Inhibition in Children for Treatment of RSV Condition: RESPIRATORY SYNCYTIAL VIRUS INFECTIONS Date: 2016-01-04 Interventions: Drug: AK0529 AK0529 is a novel |